医療用腫瘍学ソフトウェアの世界市場規模調査＆予測、展開タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年

世界の医療用腫瘍学ソフトウェア市場は、2022年に約24億米ドルと評価され、予測期間2023-2030年には7.5％以上の健全な成長率で成長すると予測されています。

腫瘍学医療ソフトウェアは、化学療法、標的療法、免疫療法、ホルモン療法などの全身的ながん治療を正確に行う上でヘルスケアプロバイダーをサポートする、重要な腫瘍学情報システムです。このソフトウェアは、患者のデータ管理、治療計画、投薬スケジュール、臨床意思決定支援、腫瘍医の治療副作用モニタリングなどを効率化します。市場全体の成長には、がん罹患率の増加、腫瘍学インフォマティクスを活用した研究活動の活発化、一貫した治療戦略のための電子カルテ（EHR）導入の増加、ゲノムデータを活用した個別化治療計画の開発、医療サービスのデジタル化の進行、がん治療強化への投資の増加など、いくつかの重要な要因が寄与しています。

さらに、がん患者の急増は、患者の記録管理と治療計画に不可欠な腫瘍学医療ソフトウェアの需要を促進します。世界的に新たながん患者数が増加しており、ヘルスケアシステムに大きな負担がかかっています。診断と治療にわたる効率的な管理が必須となり、医療用腫瘍学ソフトウェアの必要性が高まっています。例えば、米国がん協会が2023年1月に発表した論文によると、2023年の新規がん患者数は195万8,310人に増加し、それに伴い米国でのがん関連死亡者数は60万9,820人になると推計・予測しています。さらに、がんの有病率は免疫力の低下により老人患者の間で高くなっており、がんの発生率をさらに高め、その結果、市場推計・予測期間を通じて市場の成長に拍車をかけています。したがって、これらの前述の要因は、2023年から2030年の推定期間中に医療用腫瘍学ソフトウェア市場の成長を推進しています。さらに、技術的進歩の増加と抗がん剤開発の急増は、予測期間中に様々な有利な機会を提供することに大きく寄与しています。しかし、サイバー攻撃やデータ侵害行為のリスクの増大、高コストと複雑な統合は、2023-2030年の予測期間を通じて市場成長の課題となっています。

世界の医療用腫瘍学ソフトウェア市場の調査で考慮された主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東＆アフリカが含まれます。北米は、集中治療の傾向の高まり、がん治療センターの設立の増加、腫瘍学ソフトウェアの技術的進歩の増加により、2022年の市場を独占しました。一方、アジア太平洋は予測期間中に最も高いCAGRで成長すると予想されています。がん罹患率の増加、高齢化人口の拡大、主なプレイヤーの出現、投資機会の拡大、腫瘍学ソフトウェアソリューションを開発する企業の増加などが、この地域全体の市場需要を大きく促進しています。例えば、2022年8月、National Cancer Grid（NCG）は、インド全土でデジタル技術とツールによるがん治療の発展を目的としたKoita Centre for Digital Oncology（KCDO）を発足させました。KCDOは、デジタルヘルスツールの採用を促進し、デジタルヘルスを実践し、ヘルスケアデータの相互運用性や電子カルテ（EMR）の採用などの技術イニシアチブを先導することで、NCG病院を支援しています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の医療用腫瘍学ソフトウェア市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 世界の医療用腫瘍学ソフトウェア市場力学

• 医療用腫瘍学ソフトウェア市場の影響分析（2020-2030年）
  • 市場促進要因
    • 一貫した治療戦略のための電子カルテ（EHR）導入の増加
    • がん患者の急増
  • 市場の課題
    • サイバー攻撃やデータ侵害行為のリスクの増大
    • 高コストと複雑な統合
  • 市場機会
    • 技術的進歩の増加
    • 抗がん剤開発の急速な普及

第4章 世界の医療用腫瘍学ソフトウェア市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 医療用腫瘍学ソフトウェアの世界市場：展開タイプ別

• 市場スナップショット
• 医療用腫瘍学ソフトウェアの世界市場：デプロイメントタイプ別、実績 - ポテンシャル分析
• 医療用腫瘍学ソフトウェアの世界市場：展開タイプ別推定・予測2020-2030年
• 医療用腫瘍学ソフトウェア市場、サブセグメント分析
  • クラウド
  • オンプレミス
  • ハイブリッド

第6章 医療用腫瘍学ソフトウェアの世界市場：用途別

• 市場スナップショット
• 医療用腫瘍学ソフトウェアの世界市場：用途別、実績 - ポテンシャル分析
• 医療用腫瘍学ソフトウェアの世界市場：用途別推定・予測2020-2030年
• 医療用腫瘍学ソフトウェア市場、サブセグメント分析
  • 治療計画
  • 患者記録管理
  • 臨床意思決定支援
  • その他

第7章 医療用腫瘍学ソフトウェアの世界市場：エンドユーザー別

• 市場スナップショット
• 医療用腫瘍学ソフトウェアの世界市場：エンドユーザー別、実績 - ポテンシャル分析
• 医療用腫瘍学ソフトウェアの世界市場：エンドユーザー別推定・予測2020～2030年
• 医療用腫瘍学ソフトウェア市場、サブセグメント分析
  • 病院および専門クリニック
  • 診断センター
  • 研究機関
  • その他

第8章 医療用腫瘍学ソフトウェアの世界市場：地域別分析

• 主要国
• 新興国
• 医療用腫瘍学ソフトウェア市場、地域別市場スナップショット
• 北米
  • 米国
    • 展開タイプの推定・予測、2020-2030年
    • アプリケーションの推定・予測、2020-2030年
    • エンドユーザーの推定・予測、2020-2030年
  • カナダ
• 欧州医療用腫瘍学ソフトウェア市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋医療用腫瘍学ソフトウェア市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの医療用腫瘍学ソフトウェア市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Epic Systems Corporation (U.S.)
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Altai, Inc. (U.S.)
  • Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.)
  • Cerner Corporation (Oracle) (U.S.)
  • American Medical Software (U.S.)
  • Elekta (Sweden)
  • EndoSoft LLC (U.S.)
  • RaySearch Laboratories (Sweden)
  • Mckesson Corporation (U.S.)
  • Koninklijke Philips N.V. (Netherlands)

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Medical Oncology Software Market, report scope
• TABLE 2.Global Medical Oncology Software Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Medical Oncology Software Market estimates & forecasts by Deployment Type 2020-2030 (USD Billion)
• TABLE 4.Global Medical Oncology Software Market estimates & forecasts by Application 2020Application 2020-2030 (USD Billion)
• TABLE 5.Global Medical Oncology Software Market estimates & forecasts by End User 2020-2030 (USD Billion)
• TABLE 6.Global Medical Oncology Software Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Medical Oncology Software Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Medical Oncology Software Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Medical Oncology Software Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Medical Oncology Software Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Medical Oncology Software Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Medical Oncology Software Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Medical Oncology Software Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.Global Medical Oncology Software Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.Global Medical Oncology Software Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16.U.S. Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17.U.S. Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18.U.S. Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20.Canada Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21.Canada Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23.UK Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24.UK Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26.Germany Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27.Germany Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29.France Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30.France Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32.Italy Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33.Italy Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35.Spain Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36.Spain Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38.RoE Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39.RoE Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41.China Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42.China Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44.India Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45.India Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47.Japan Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48.Japan Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50.South Korea Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51.South Korea Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53.Australia Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54.Australia Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56.RoAPAC Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57.RoAPAC Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59.Brazil Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60.Brazil Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62.Mexico Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63.Mexico Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65.RoLA Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66.RoLA Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.Saudi Arabia Medical Oncology Software Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68.South Africa Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69.RoMEA Medical Oncology Software Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70.List of secondary sources, used in the study of global Medical Oncology Software Market
• TABLE 71.List of primary sources, used in the study of global Medical Oncology Software Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Medical Oncology Software Market, research methodology
• FIG 2.Global Medical Oncology Software Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Medical Oncology Software Market, key trends 2022
• FIG 5.Global Medical Oncology Software Market, growth prospects 2023-2030
• FIG 6.Global Medical Oncology Software Market, porters 5 force model
• FIG 7.Global Medical Oncology Software Market, pest analysis
• FIG 8.Global Medical Oncology Software Market, value chain analysis
• FIG 9.Global Medical Oncology Software Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Medical Oncology Software Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Medical Oncology Software Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Medical Oncology Software Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Medical Oncology Software Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Medical Oncology Software Market, regional snapshot 2020 & 2030
• FIG 15.North America Medical Oncology Software Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Medical Oncology Software Market 2020 & 2030 (USD Billion)
• FIG 17.Asia pacific Medical Oncology Software Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Medical Oncology Software Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Medical Oncology Software Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Medical Oncology Software Market is valued at approximately USD 2.40 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% over during the forecast period 2023-2030. Medical oncology software is a vital oncology informatics system, supporting healthcare providers in the precise administration of systemic cancer treatments such as chemotherapy, targeted therapy, immunotherapy, and hormone therapy. This software streamlines patient data management, treatment planning, medication scheduling, clinical decision support, and monitoring of treatment side effects for oncologists. The overall market growth is fueled by several key factors, including the increasing prevalence of cancer, a rise in research activities utilizing oncology informatics, rising adoption of Electronic Health Records (EHR) for cohesive treatment strategies, development of personalized treatment plans using genomic data the ongoing digitization of healthcare services, and increased investment in enhancing cancer care.

In addition, the surge in cancer cases is set to propel the demand for medical oncology software, crucial for patient record management and treatment planning. There is a significant strain on healthcare systems with the increasing number of new cancer cases globally. Efficient management across diagnosis and treatment becomes imperative, intensifying the need for medical oncology software. For instance, an article published by the American Cancer Society in January 2023 forecasts a rise in new cancer cases to 1,958,310 in 2023, accompanied by an estimated 609,820 cancer-related deaths in the U.S. Additionally, cancer prevalence is higher among geriatric patients due to weakened immunity, further driving the incidence of cancer and consequently fueling market growth throughout the forecast period. Thus, these aforementioned factors are propelling the growth of the Medical Oncology Software Market during the estimated period of 2023-2030. Furthermore, increasing technological advancements and the proliferation of cancer drug development significantly contribute to the present various lucrative opportunities over the forecast years. However, the growing risk of cyber-attacks and data breaching activities and the high cost and complex integration are is challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Medical Oncology Software Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising trend of centralized care, the growing establishment of cancer care centers, and the increase in technological advancements in oncology software. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increase in the incidence of cancer, the expanding aging population, the emergence of key players, growing investment opportunities, and an increasing influx of companies developing oncology software solutions are significantly propelling the market demand across the region. For instance, in August 2022, The National Cancer Grid (NCG) inaugurated the Koita Centre for Digital Oncology (KCDO) aimed at advancing cancer care through digital technologies and tools across India. The KCDO supports NCG hospitals by facilitating the adoption of digital health tools, implementing digital health practices, and spearheading technology initiatives such as healthcare data interoperability and Electronic Medical Record (EMR) adoption.

Major market players included in this report are:

• Epic Systems Corporation (U.S.)
• Altai, Inc. (U.S.)
• Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.)
• Cerner Corporation (Oracle) (U.S.)
• American Medical Software (U.S.)
• Elekta (Sweden)
• EndoSoft LLC (U.S.)
• RaySearch Laboratories (Sweden)
• Mckesson Corporation (U.S.)
• Koninklijke Philips N.V. (Netherlands)

Recent Developments in the Market:

• In April 2023, Epic Systems Corporation announced an expansion of its collaboration with Microsoft, focusing on integrating generative artificial Artificial intelligence Intelligence (AI) technology into electronic health records. This partnership aims to enhance providers' productivity, alleviate administrative burdens, and elevate patient care by granting clinicians more time to dedicate to their patients.
• In February 2023, Varian Medical Systems, Inc., operating under Siemens Healthineers, unveiled its collaboration with Nova Scotia Health to expedite the digital transformation of the health system's comprehensive oncology service line. Through this collaboration, Varian Medical Systems, Inc. endeavours to offer a range of multidisciplinary oncology solutions aimed at fostering connectivity among cancer patients and optimizing patient care across their entire cancer care continuum.

Global Medical Oncology Software Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Deployment Type, Application, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Deployment Type:

• Clouds
• On-premise
• Hybrid

By Application:

• Treatment Planning
• Patient Record Management
• Clinical Decision Support
• Others

By End User:

• Hospitals & Specialty Clinics
• Diagnostic Centers
• Research Institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Medical Oncology Software Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Medical Oncology Software Market, by Deployment Type, 2020-2030 (USD Billion)
  • 1.2.3.Medical Oncology Software Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Medical Oncology Software Market, by End User, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Medical Oncology Software Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Medical Oncology Software Market Dynamics

• 3.1.Medical Oncology Software Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing adoption of Electronic Health Records (EHR) for cohesive treatment strategies
    • 3.1.1.2.Surge in cancer cases
  • 3.1.2.Market Challenges
    • 3.1.2.1.Growing risk of cyber-attack and data breaching activities
    • 3.1.2.2.High cost and complex integration
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Increasing technological advancements
    • 3.1.3.2.Rapid proliferation of cancer drug development

Chapter 4.Global Medical Oncology Software Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Medical Oncology Software Market, by Deployment Type

• 5.1.Market Snapshot
• 5.2.Global Medical Oncology Software Market by Deployment Type, Performance - Potential Analysis
• 5.3.Global Medical Oncology Software Market Estimates & Forecasts by Deployment Type 2020-2030 (USD Billion)
• 5.4.Medical Oncology Software Market, Sub Segment Analysis
  • 5.4.1.Clouds
  • 5.4.2.On-premise
  • 5.4.3.Hybrid

Chapter 6.Global Medical Oncology Software Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Medical Oncology Software Market by Application, Performance - Potential Analysis
• 6.3.Global Medical Oncology Software Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Medical Oncology Software Market, Sub Segment Analysis
  • 6.4.1.Treatment Planning
  • 6.4.2.Patient Record Management
  • 6.4.3.Clinical Decision Support
  • 6.4.4.Others

Chapter 7.Global Medical Oncology Software Market, by End User

• 7.1.Market Snapshot
• 7.2.Global Medical Oncology Software Market by End User, Performance - Potential Analysis
• 7.3.Global Medical Oncology Software Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4.Medical Oncology Software Market, Sub Segment Analysis
  • 7.4.1.Hospitals & Specialty Clinics
  • 7.4.2.Diagnostic Centers
  • 7.4.3.Research Institutes
  • 7.4.4.Others

Chapter 8.Global Medical Oncology Software Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Medical Oncology Software Market, Regional Market Snapshot
• 8.4.North America Medical Oncology Software Market
  • 8.4.1.U.S. Medical Oncology Software Market
    • 8.4.1.1.Deployment Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Medical Oncology Software Market
• 8.5.Europe Medical Oncology Software Market Snapshot
  • 8.5.1.U.K. Medical Oncology Software Market
  • 8.5.2.Germany Medical Oncology Software Market
  • 8.5.3.France Medical Oncology Software Market
  • 8.5.4.Spain Medical Oncology Software Market
  • 8.5.5.Italy Medical Oncology Software Market
  • 8.5.6.Rest of Europe Medical Oncology Software Market
• 8.6.Asia-Pacific Medical Oncology Software Market Snapshot
  • 8.6.1.China Medical Oncology Software Market
  • 8.6.2.India Medical Oncology Software Market
  • 8.6.3.Japan Medical Oncology Software Market
  • 8.6.4.Australia Medical Oncology Software Market
  • 8.6.5.South Korea Medical Oncology Software Market
  • 8.6.6.Rest of Asia Pacific Medical Oncology Software Market
• 8.7.Latin America Medical Oncology Software Market Snapshot
  • 8.7.1.Brazil Medical Oncology Software Market
  • 8.7.2.Mexico Medical Oncology Software Market
• 8.8.Middle East & Africa Medical Oncology Software Market
  • 8.8.1.Saudi Arabia Medical Oncology Software Market
  • 8.8.2.South Africa Medical Oncology Software Market
  • 8.8.3.Rest of Middle East & Africa Medical Oncology Software Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.Epic Systems Corporation (U.S.)
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Altai, Inc. (U.S.)
  • 9.3.3.Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.)
  • 9.3.4.Cerner Corporation (Oracle) (U.S.)
  • 9.3.5.American Medical Software (U.S.)
  • 9.3.6.Elekta (Sweden)
  • 9.3.7.EndoSoft LLC (U.S.)
  • 9.3.8.RaySearch Laboratories (Sweden)
  • 9.3.9.Mckesson Corporation (U.S.)
  • 9.3.10.Koninklijke Philips N.V. (Netherlands)

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption